Legato Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Sell |
4,301
-5,680
| -57% | -$593K | 0.05% | 452 |
|
|
2025
Q1 | $1.16M | Buy |
+9,981
| New | +$1.16M | 0.16% | 211 |
|
|
2024
Q2 | – | Sell |
-4,733
| Closed | -$378K | – | 564 |
|
|
2024
Q1 | $378K | Sell |
4,733
-3,889
| -45% | -$310K | 0.05% | 481 |
|
|
2023
Q4 | $686K | Hold |
8,622
| – | – | 0.09% | 350 |
|
|
2023
Q3 | $603K | Sell |
8,622
-3,330
| -28% | -$233K | 0.09% | 355 |
|
|
2023
Q2 | $859K | Buy |
11,952
+4,925
| +70% | +$354K | 0.12% | 291 |
|
|
2023
Q1 | $433K | Hold |
7,027
| – | – | 0.08% | 379 |
|
|
2022
Q4 | $542K | Buy |
+7,027
| New | +$542K | 0.1% | 329 |
|